e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Cellular signalling mechanisms in the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
TLR2 and TLR4 induced tolerance in alveolar macrophages; differential effect on TNFα and IL-8 release
S. Reynolds, M. Kaur, M. Beardsall, S. Lea, S. Hall, D. Singh (Stevenage, United Kingdom)
Source:
Annual Congress 2012 - Cellular signalling mechanisms in the airways
Session:
Cellular signalling mechanisms in the airways
Session type:
Poster Discussion
Number:
3408
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Reynolds, M. Kaur, M. Beardsall, S. Lea, S. Hall, D. Singh (Stevenage, United Kingdom). TLR2 and TLR4 induced tolerance in alveolar macrophages; differential effect on TNFα and IL-8 release. Eur Respir J 2012; 40: Suppl. 56, 3408
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin
Source: Eur Respir J 2006; 28: 622-626
Year: 2006
LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9
Source: Eur Respir J 2002; 20: 1198-1205
Year: 2002
Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 588s
Year: 2003
Late-breaking abstract: Activation of the macrophage inflammasome by TLR3 ligation potentiates release of IL-8 and IP-10 from alveolar type II epithelial cells via a paracrine cytokine network
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011
Effects of extracellular Hsp70, lipoteichoic acid and lipopolysaccharide on TLR2 and TLR4 mRNA expression in monocyte-derived macrophages
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Pattern recognition receptor expression and LPS binding capacity of human monocytes and alveolar macrophages
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002
Glucocorticoids induce a shift in chemokine profile in LPS-stimulated human alveolar macrophages
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001
Exaggerated IL-6 responses to LPS after viral airway infection in mice is mediated by endogenous TNF-a production
Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens
Year: 2007
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
IgA inhibits LPS-induced IL-10 in human alveolar macrophages (HAM)
Source: Eur Respir J 2005; 26: Suppl. 49, 585s
Year: 2005
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Activation of PAR-2 enhances ICAM-1 expression and IL-8 release in airway epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002
The relationship between PBMC secretion of IFN-alpha following TLR7 and TLR9 activation and lung function in COPD
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
IL-4/13-induced up-regulation of METEORIN-LIKE (ML) in alveolar macrophages promotes epithelial CCR3 expression
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α
Source: Eur Respir J 2003; 21: 387-393
Year: 2003
Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003
Chemokinome characterization in human lung macrophages following stimulation with Th2-type cytokines IL-4 or IL-13
Source: Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept